Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers - Concepedia

Concepedia

Publication | Open Access

Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers

DOI Full Paper Access

124

Citations

39

References

2015

Year

Guoyan Liu, Da Yang, Rajesha Rupaimoole, Chad V. Pecot, Yan Sun, Lingegowda S. Mangala, Xia Li, Ping Ji, David Cogdell, Limei Hu,

JNCI Journal of the National Cancer Institute

Abstract

MiR-506 is a robust clinical marker for chemotherapy response and survival in serous ovarian cancers and has important therapeutic value in sensitizing cancer cells to chemotherapy.

References

	Year	Citations
Cancer statistics, 2013 Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal CA A Cancer Journal for Clinicians	2013	11.9K
Adjusting batch effects in microarray expression data using empirical Bayes methods W. Evan Johnson, Cheng Li, Ariel Rabinovic Biostatistics	2006	8.7K
Integrated genomic analyses of ovarian carcinoma Debra Bell, Andrew Berchuck, Wendy Winckler Nature Tumor HeterogeneityGynecologyCancer GenomicsOvarian CarcinomaMolecular Diagnostics	2011	8K
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy Hannah Farmer, Nuala McCabe, Christopher J. Lord, Nature Genome InstabilityDna DamageBrca Mutant CellsMedicineMolecular Biology	2005	6.5K
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase Helen E. Bryant, Niklas Schultz, Huw D. Thomas, Nature Tumor BiologyOncologyMedicinePathologyAnti-cancer Agent	2005	5.1K
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers Peter C.C. Fong, David S. Boss, Timothy A. Yap, New England Journal of Medicine	2009	3.6K
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial M. William Audeh, James Carmichael, Richard T. Penson, The Lancet MedicineCancer ManagementGynecologyRecurrent Ovarian CancerPolymerase Inhibitor Olaparib	2010	2.3K
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer Jonathan A. Ledermann, Philipp Harter, Charlie Gourley, New England Journal of Medicine	2012	1.9K
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model Janaiah Kota, Raghu R. Chivukula, Kathryn A. O’Donnell, Cell Tumor BiologyMedicineLiver PhysiologyMicrorna DetectionLiver Cancer	2009	1.7K
Regulation by let-7 and lin-4 miRNAs Results in Target mRNA Degradation Shveta Bagga, John R. Bracht, Shaun Hunter, Cell Target Mrna DegradationGeneticsRna BiologyMicrorna DetectionCell Biology	2005	1.3K

Page 1